Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyBone Marrow TransplantationGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanTreatment OutcomeMyeloablative AgonistsMultiple MyelomaStem CellsAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicRetrospective StudiesImmunosuppressive AgentsVidarabineAmyloidosisHematopoiesisSalvage TherapyLeukemiaIfosfamideSurvival RateVincristineSurvival AnalysisCarmustineBlood CellsGraft vs Leukemia EffectCytarabineHodgkin DiseaseTime FactorsLeukemia, Myeloid, AcutePlatelet CountMyelodysplastic SyndromesCytomegalovirus InfectionsAnemia, AplasticBlood Cell CountLymphomaLiver TransplantationCytophagocytosisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionNeoplasmsFatal OutcomeFollow-Up StudiesFeasibility StudiesLivedo ReticularisHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsHematologic DiseasesDoxorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineHLA AntigensBlood DonorsBone MarrowImmunophenotypingProspective StudiesImmunosuppressionRecombinant ProteinsMesenchymal Stem Cell TransplantationLymphoma, T-CellPilot ProjectsBone Marrow PurgingPrednisoneCarboplatinBone Marrow DiseasesPrognosisAntigens, CDBlood Group IncompatibilityKidney TransplantationNeoplasm, ResidualAntineoplastic Agents